Intravenous immunoglobulin for post-polio syndrome
Samuelsson O, Danielsson A, Nordin J, Sunnerhagen KS, Svanberg T
Record ID 32016000594
English
Authors' recommendations:
Intravenous treatment with high doses of immunoglobulin is an expensive therapy. In controlled trials this treatment has not been shown to have any beneficial effects in patients with post-polio syndrome.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www2.sahlgrenska.se/upload/SU/HTA-centrum/HTA-rapporter/HTA-report%20Intravenous%20immunoglobulin%20for%20post-polio%20syndrome%202014-10-01%20till%20publicering.pdf
URL for additional information:
http://www.sahlgrenska.se/sv/SU/Forskning/HTA-centrum/Hogerkolumn-undersidor/Publicerade-rapporter/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
MeSH Terms
- Humans
- Immunoglobulins, Intravenous
- Postpoliomyelitis Syndrome
Contact
Organisation Name:
The Regional Health Technology Assessment Centre
Contact Address:
The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden
Contact Name:
hta-centrum@vgregion.se
Contact Email:
hta-centrum@vgregion.se
Copyright:
The Regional Health Technology Assessment Centre (HTA-centrum), Region Vastra Gotaland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.